RAPT THERAPEUTICS, INC. (RAPT) Social Stream
RAPT Therapeutics Inc (RAPT) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering RAPT.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 48 weeks, RAPT's average price target has gone up $21.3.
Over the past 50 weeks, RAPT's average upside potential has been 101.13%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
RAPT Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
RAPT's average broker recommendation rating improved by 1 over the prior 30 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, RAPT Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 593.29% of them.
- RAPT Therapeutics Inc's number of analysts covering the stock is higher than 221.39% of all US stocks.
- RAPT Therapeutics Inc's average analyst price target is greater than 645.22% of stocks in the small market cap category.
- In terms of how RAPT Therapeutics Inc fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -125.57% of that group.
In the Pharmaceutical Products industry, RANI, RAIN, and PYXS are the three stocks most similar to RAPT Therapeutics Inc regarding the price target and analyst recommendation information presented here.
Is RAPT a Buy, Hold or Sell? See the POWR Ratings now!